B-precursor Acute Lymphoblastic Leukemia
5 clinical trials · Condition
◉ Watch B-precursor Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) (NCT04506086) | Amgen | 2021-08-26 |
| GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL (NCT04601584) | AO GENERIUM | 2020-10-15 |
| Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL (NCT03123887) | Harbin Hematology and Oncology Institute | 2015-07-10 |
Track B-precursor Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.